在线国产一区二区_成人黄色片在线观看_国产成人免费_日韩精品免费在线视频_亚洲精品美女久久_欧美一级免费在线观看

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Americas

Hydroxychloroquine fails to prevent COVID-19: trial

Xinhua | Updated: 2020-06-04 14:06
Share
Share - WeChat
The drug hydroxychloroquine is displayed at the Rock Canyon Pharmacy in Provo, Utah, US, May 27, 2020. [Photo/Agencies]

CHICAGO - Hydroxychloroquine, an anti-malaria drug, was not statistically effective in preventing infection for people exposed to the novel coronavirus, a clinical trial showed on Wednesday.

The experiment, led by a team at the University of Minnesota, the United States, in March, was the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19, according to the university.

Researchers enrolled 821 adults from the United States and Canada, who had come into contact with someone confirmed with COVID-19 for more than 10 minutes at a distance of six feet (1.83 meters) or less.

All the participants were randomly assigned to receive either hydroxychloroquine, or a vitamin placebo, for five days.

Over the next two weeks, against laboratory test and from clinical signs, researchers found that 49 of the 414, or 11.83 percent, given the medicine got the COVID-19, compared to 58 of the 407, or 14.25 percent, on the placebo.

The scientists said the difference of about 2.4 percentage points in favor of the medicine was not considered statistically significant, which means hydroxychloroquine has no benefit over placebo in COVID-19 prevention.

Side effects, however, were more common with hydroxychloroquine group than those on the placebo -- 40.1 percent versus 16.8 percent -- no serious ones were reported though.

The trial results has been published in the New England Journal of Medicine.

US President Donald Trump has said he used it as a prophylaxis against COVID-19, but the Food and Drug Administration cautioned in late April against the use of it outside of the hospital setting due to the risk of cardiac rhythm problems.

As of 0100 GMT Thursday, confirmed COVID-19 cases have passed 6.3 million globally, with 383,318 deaths, showed the tally of Center for Systems Science and Engineering at Johns Hopkins University.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 黄色大片免费在线观看 | 欧美精品久久 | av大片在线观看 | 欧美日韩中文字幕在线观看 | 久久av片 | 日韩成人在线观看 | 一级片黄色 | 日韩一区二区三区在线 | 一级黄色大片 | 国产欧美视频在线观看 | 国产中文字幕在线播放 | 免费av小说| 伊人国产在线 | 日韩福利视频 | 亚洲欧洲天堂 | 一级做a爱片性色毛片 | 亚洲综合精品 | 欧美午夜理伦三级在线观看 | 国产在线欧美 | 一级做a爱片性色毛片 | 五月婷婷中文字幕 | 国产视频一二区 | 久久免费影院 | 美女黄色在线观看 | 国产黄色免费网站 | 国产久| 成人深夜福利视频 | 精品久久久久久久久久久久久久久久 | 欧美区一区二 | 精品一区二区三区在线观看 | 精品欧美日韩 | 亚洲视频一区二区三区四区 | 成人黄性视频 | 天天干夜夜爽 | 夜夜操狠狠操 | 手机看片国产 | 天堂成人网 | xxxx色| www.欧美日韩 | 欧美不卡一区 | 日韩一级黄色片 |